Clinical trial
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
NCT00028574 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00028574 |
|---|---|
| Title | Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer |
| Official title | A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes, Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | gabapentin, placebo |
| Enrollment | 223 |
| Start date | Dec 1, 2001 |
| Primary completion | Dec 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 28, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: